Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
For patients with obesity and elevated alk phos who have RA, do you check a fibroscan or serum NASH fibrosure test before starting methotrexate or leflunomide?
Related Questions
Would you escalate therapy in a patient with rheumatoid arthritis without synovitis, but a new rheumatoid nodule?
How would you manage a patient with erosive seronegative rheumatoid arthritis with IgG and IgM deficiency?
How do you approach venous insufficiency management in patients on Jak inhibitors?
Would you continue Jak inhibitor therapy in a patient with long standing, previously refractory RA in their 60s who was found to have stenosis of the left common femoral artery and no other history of arteriosclerotic disease?
How would you approach a patient with anti-scl70 ab positive sine scleroderma complicated by ILD who also has seropositive RA with active arthritis?
How do you approach treatment of a patient with active RA and a history of Lynch Syndrome?
How do you approach monitoring when using combination JAK inhibitors and methotrexate in RA?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?
How do you approach patients with RA and severe bronchiectasis with associated findings of UIP?
How do you approach management of DMARDs and biologics in a patient with active RA, but frequent recurrent simple UTIs?
